Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (487)	1/26/2004 11:49:42 AM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

GLFD Briefly made a 52wks. H today as it traded above its January 12 H while making an intraday double top at 10AM at the 9.62 level.<g> Today's volume of 471K is still below its daily average. bigcharts.marketwatch.com GLFD is making an aggressive marketing of the AGGRASTAT Injection (tirofiban hydrochloride)for use in ACS, after it obtained from MRK the US distribution rights. it also plans to start a PIII later this year for using AGGRASTAT in patients undergoing PTCA. If the stock can close above its resistance at the $10 level it could get to test the $15 resistance later this year.<g> bigcharts.marketwatch.com Bernard